Sen. Tillis Seeks Answers on Unprecedented Drug Price Control Scheme That Threatens Innovation, Future Drug Costs
September 20, 2022
September 20, 2022
WASHINGTON, Sept. 20 -- Sen. Thom Tillis, R-North Carolina, issued the following news release and letter:
Recently, U.S. Senator Thom Tillis (R-NC) and Senate Republicans expressed concerns with the establishment of a permanent government drug price-setting program, funded by billions of taxpayer dollars in the partisan Inflation Reduction Act, and raised questions regarding federal health agencies' plans for program implementation.
In a letter to Health and Human . . .
Recently, U.S. Senator Thom Tillis (R-NC) and Senate Republicans expressed concerns with the establishment of a permanent government drug price-setting program, funded by billions of taxpayer dollars in the partisan Inflation Reduction Act, and raised questions regarding federal health agencies' plans for program implementation.
In a letter to Health and Human . . .